Matheus Mittmann Hennemann

ORCID: 0000-0001-8323-0300
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pulmonary Hypertension Research and Treatments
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • S100 Proteins and Annexins
  • Intensive Care Unit Cognitive Disorders
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac and Coronary Surgery Techniques
  • Epilepsy research and treatment
  • Renin-Angiotensin System Studies
  • RNA modifications and cancer
  • Nitric Oxide and Endothelin Effects
  • Vitamin C and Antioxidants Research
  • Neuroscience and Neuropharmacology Research
  • Mechanical Circulatory Support Devices
  • Lung Cancer Research Studies
  • Cardiovascular and exercise physiology
  • Cardiac Valve Diseases and Treatments

Universidade Federal do Rio Grande do Sul
2017-2018

Hospital São Lucas da PUCRS
2009

e19080 Background: The excision repair cross-complementation group 1 (ERCC1) protein expression has been suggested as both predictive or prognostic according to the administration not of cisplatin-based chemotherapy in non-small cell lung cancer. It's role small cancer (SCLC) is still uncertain. Methods: Forty four patients (pts) with diagnosis SCLC were retrospectively analyzed. Paraffin blocks reviewed reconfirm a and submitted semi-quantitative immunohistochemical (ICH) method detect...

10.1200/jco.2009.27.15_suppl.e19080 article EN Journal of Clinical Oncology 2009-05-20
Coming Soon ...